ABI
AET

Adamant Biomedical Investments’s Aetna Inc AET Stock Holding History

Adamant Biomedical Investments’s Portfolio AET Stock Details AET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3.91M Sell
44,000
-16,000
-27% -$1.34M 0.93% 42
2014
Q3 		$4.86M Buy
+60,000
New +$4.88M 1.21% 29

Other funds holding AET

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Adamant Biomedical Investments's AET Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Aetna Inc (AET) stake by 27% in Q4 2014, selling an estimated $1.34M and leaving 44,000 shares worth $3.91M. The position accounts for 0.93% of the portfolio, ranked #42.

Adamant Biomedical Investments first reported a position in AET in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.86M in Q3 2014. 755 funds tracked by Wall St. Rank hold AET as of Q4 2014.

  • Adamant Biomedical Investments held 44,000 shares of Aetna Inc worth $3.91M as of Q4 2014.
  • Adamant Biomedical Investments sold 16,000 Aetna Inc shares in Q4 2014, an estimated $1.34M.
  • Aetna Inc made up 0.93% of Adamant Biomedical Investments's portfolio in Q4 2014, its #42 holding.
  • Adamant Biomedical Investments first reported a position in Aetna Inc in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Aetna Inc position peaked at $4.86M in Q3 2014.
  • 755 funds tracked by Wall St. Rank held Aetna Inc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.